Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 423 | 37 | 93 | 61 | 247 |
| Receivables | 22 | 40 | 13 | 12 | 36 |
| Other current assets | 347 | 248 | 404 | 327 | 439 |
| TOTAL | $793 | $325 | $510 | $400 | $722 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $793 | $325 | $510 | $400 | $722 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22 | N/A | 80 | 80 | 80 |
| Accounts payable and accrued liabilities | 4,595 | 4,977 | 5,329 | 5,079 | 5,119 |
| Other current liabilities | 0 | 4 | 12 | N/A | N/A |
| TOTAL | $6,376 | $6,827 | $6,381 | $6,801 | $6,515 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,240 | 328 | N/A | N/A | N/A |
| Other Non-Current Liabilities | -2,670 | -2,838 | -2,248 | -2,147 | -2,315 |
| TOTAL | $2,191 | $1,194 | $806 | $573 | $609 |
| Total Liabilities | $8,568 | $8,021 | $7,187 | $7,374 | $7,124 |
| Shareholders' Equity | |||||
| Common Shares | 78,479 | 78,460 | 78,340 | 78,102 | 77,926 |
| Retained earnings | -117,023 | -115,076 | -113,773 | -113,578 | -112,558 |
| Other shareholders' equity | 27,738 | 25,808 | 26,253 | 25,979 | 25,628 |
| TOTAL | $-10,805 | $-10,809 | $-9,181 | $-9,496 | $-9,005 |
| Total Liabilities And Equity | $-2,238 | $-2,788 | $-1,994 | $-2,122 | $-1,880 |